4D Molecular Therapeutics, Inc. (FDMT) stock
FDMTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/3015% below fair value
$10.79−0.50 (-4.43%)
Close on Nov 17, 2026Market cap $778.82MP/E –Yield –
4D Molecular Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
4D Molecular Therapeutics's revenue for the twelve months ending Jun 30, 2026 was $92.01M, up 278712.1% year over year. For fiscal 2025 it was $85.21M, up 230194.6% from the year before. The highest annual figure on record is $85.21M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $85.21M | +230194.6% |
| FY2024 | Dec 31, 2024 | $37.00K | -99.8% |
| FY2023 | Dec 31, 2023 | $20.72M | +562.3% |
| FY2022 | Dec 31, 2022 | $3.13M | -82.7% |
| FY2021 | Dec 31, 2021 | $18.04M | +32.5% |
| FY2020 | Dec 31, 2020 | $13.61M | +94.8% |
| FY2019 | Dec 31, 2019 | $6.99M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $3.78M | +25106.7% |
| Q1 FY2026 | Mar 31, 2026 | $3.05M | +21664.3% |
| Q4 FY2025 | Dec 31, 2025 | $85.09M | +8508900.0% |
| Q3 FY2025 | Sep 30, 2025 | $90.00K | +2900.0% |
| Q2 FY2025 | Jun 30, 2025 | $15.00K | +200.0% |
| Q1 FY2025 | Mar 31, 2025 | $14.00K | -50.0% |
| Q4 FY2024 | Dec 31, 2024 | $1.00K | -100.0% |
| Q3 FY2024 | Sep 30, 2024 | $3.00K | -98.7% |
| Q2 FY2024 | Jun 30, 2024 | $5.00K | -98.3% |
| Q1 FY2024 | Mar 31, 2024 | $28.00K | -97.8% |
| Q3 FY2023 | Sep 30, 2023 | $20.20M | +3940.8% |
| Q2 FY2023 | Jun 30, 2023 | $239.00K | +47.5% |
| Q1 FY2023 | Mar 31, 2023 | $298.00K | -75.6% |
| Q4 FY2022 | Dec 31, 2022 | $1.25M | +1255.4% |
| Q3 FY2022 | Sep 30, 2022 | $500.00K | -63.4% |
| Q2 FY2022 | Jun 30, 2022 | $162.00K | -98.9% |
| Q1 FY2022 | Mar 31, 2022 | $1.22M | -39.0% |
| Q4 FY2021 | Dec 31, 2021 | $92.00K | -98.8% |
| Q3 FY2021 | Sep 30, 2021 | $1.37M | -62.4% |
| Q2 FY2021 | Jun 30, 2021 | $14.58M | +312.4% |
| Q1 FY2021 | Mar 31, 2021 | $2.00M | – |
| Q3 FY2020 | Sep 30, 2020 | $7.42M | – |
| Q2 FY2020 | Jun 30, 2020 | $3.63M | – |
| Q1 FY2020 | Mar 31, 2020 | $3.54M | – |
See a number that looks wrong?